PDHB and lung carcinoma: FDX1 affects the prognosis of lung cancer by altering the expression of cuproptosis-related signature (GLS, PDHA1, PDHB, MTF1, and DLAT), which more strongly confirms that the prognosis of lung cancer patients is closely related to the occurrence of cuproptosis.